Allakos (ALLK) stock forecast for 2026
Last update: 08-15-2022, 12:56
Sector: HealthcareThe share price of Allakos Inc. (ALLK) now
What analysts predict:: $7.11
52-week high/low: $112.87 / $2.54
50/200 Day Moving Average: $3.398 / $20.49
This figure corresponds to the average price over the previous 50/200 days. For Allakos stocks, the 50-day moving average is the support level today.
For Allakos stocks, the 200-day moving average is the resistance level today.
Are you interested in Allakos stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Allakos stock price in 2026. How much will one Allakos share be worth in 2026?
Is it worth taking profit / loss on Allakos stock now or waiting? What are analysts' forecasts for Allakos stock?
We forecast Allakos stock performance using neural networks based on historical data on Allakos stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The Allakos stock prediction results are shown below and presented as a graph, table and text information.
Allakos stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Allakos analysts is $7.11.
Today 200 Day Moving Average is the resistance level (20.49 $).
50 Day Moving Average is the support level (3.398 $).
Historical and forecast chart of Allakos stock
The chart below shows the historical price of Allakos stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Allakos stock price can be found in the table below.
Allakos (ALLK) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 5.34 | 4.99 | 5.77 | 13.43 % |
| Feb | 5.43 | 5.19 | 5.59 | 7.10 % |
| Mar | 5.48 | 5.12 | 5.71 | 10.37 % |
| Apr | 5.52 | 5.16 | 5.77 | 10.62 % |
| May | 5.35 | 5.02 | 5.68 | 11.59 % |
| Jun | 5.30 | 5.01 | 5.42 | 7.71 % |
| Jul | 5.79 | 5.58 | 5.91 | 5.59 % |
| Aug | 5.89 | 5.75 | 6.34 | 9.21 % |
| Sep | 6.22 | 5.79 | 6.52 | 11.17 % |
| Oct | 6.02 | 5.61 | 6.34 | 11.50 % |
| Nov | 6.16 | 5.97 | 6.63 | 9.93 % |
| Dec | 6.20 | 5.88 | 6.34 | 7.23 % |
Allakos information and performance
Allakos Inc. Is a biotechnology company headquartered in Redwood City, PA. California specializing in clinical research and development of antibodies for the treatment of various diseases associated with mast cells and eosinophils. Was founded in 2012.
Allakos Address
975 ISLAND DRIVE, SUITE 201, REDWOOD CITY, CA, US
Market Capitalization: 208 956 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -388 936 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -7.59
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: -0.124
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 54844000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Allakos price target for 2021 by month
Target values for the price of one Allakos share for Jan 2026.
Pessimistic target level: 4.99
Optimistic target level: 5.77
Target values for the price of one Allakos share for Feb 2026.
Pessimistic target level: 5.19
Optimistic target level: 5.59
Target values for the price of one Allakos share for Mar 2026.
Pessimistic target level: 5.12
Optimistic target level: 5.71
Target values for the price of one Allakos share for Apr 2026.
Pessimistic target level: 5.16
Optimistic target level: 5.77
Target values for the price of one Allakos share for May 2026.
Pessimistic target level: 5.02
Optimistic target level: 5.68
Target values for the price of one Allakos share for Jun 2026.
Pessimistic target level: 5.01
Optimistic target level: 5.42
Target values for the price of one Allakos share for Jul 2026.
Pessimistic target level: 5.58
Optimistic target level: 5.91
Target values for the price of one Allakos share for Aug 2026.
Pessimistic target level: 5.75
Optimistic target level: 6.34
Target values for the price of one Allakos share for Sep 2026.
Pessimistic target level: 5.79
Optimistic target level: 6.52
Target values for the price of one Allakos share for Oct 2026.
Pessimistic target level: 5.61
Optimistic target level: 6.34
Target values for the price of one Allakos share for Nov 2026.
Pessimistic target level: 5.97
Optimistic target level: 6.63
Target values for the price of one Allakos share for Dec 2026.
Pessimistic target level: 5.88
Optimistic target level: 6.34
